Clovis Oncology, Inc. Current Foreign Tax Expense (Benefit)
Clovis Oncology, Inc. reported Current Foreign Tax Expense (Benefit) of -$422.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2022-02-24
- Clovis Oncology, Inc. current foreign tax expense (benefit) for fiscal 2021 was -$422.00K.
- Clovis Oncology, Inc. current foreign tax expense (benefit) for fiscal 2020 was -$597.00K, a 133.26% decline from fiscal 2019.
- Clovis Oncology, Inc. current foreign tax expense (benefit) for fiscal 2019 was $1.79M, a 202.70% increase from fiscal 2018.
- Clovis Oncology, Inc. current foreign tax expense (benefit) for fiscal 2018 was $593.00K.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2021-12-31 | -$422.00K 10-K · filed 2022-02-24 |
| 2020-12-31 | -$597.00K 10-K · filed 2022-02-24 |
| 2019-12-31 | $1.79M 10-K · filed 2022-02-24 |
| 2018-12-31 | $593.00K 10-K · filed 2021-02-25 |
| 2017-12-31 | -$360.00K 10-K · filed 2020-02-26 |
| 2016-12-31 | $64.00K 10-K · filed 2019-02-28 |
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 |
| 2014-12-31 | $1.55M 10-K · filed 2017-02-23 |